Other Global Peers |
BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SEAGEN INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), ALNYLAM PHARMACEUTICALS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ZAI LAB-SB (HKEx), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NOVAVAX INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), ACCELERON PHARMA (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), JOINN (HKEx), ALLOGENE THERAPEUTICS INC (NASDAQ), SANA BIOTECHNOLOGY INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), GENSCRIPT BIO (HKEx), RELAY THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), SEER INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALKERMES PLC (NASDAQ), VIELA BIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), NANTKWEST INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), LIGAND PHARMACEUTICAL INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), ALLOVIR INC (NASDAQ), NUVATION BIO INC (NYSE), BIONANO GENOMICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), IMMUNOCORE HLDGS PLC SPON ADS EACH REP ONE ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), OCUGEN INC (NASDAQ), JACOBIO-B (HKEx), AURINIA PHARMACEUTICALS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), JW THERAP-B (HKEx), ZENTALIS PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), REGENXBIO INC (NASDAQ), PRECIGEN INC (NASDAQ), BIOATLA INC (NASDAQ), ALPHAMAB-B (HKEx), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), SERES THERAPEUTICS (NASDAQ), TRANSLATE BIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), UNIQURE N.V. (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NKARTA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VOR BIOPHARMA INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUNOVANT INC (NASDAQ), CYTOKINETICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), VAXCYTE INC (NASDAQ), ALECTOR INC (NASDAQ), HAOHAI BIOTEC (HKEx), FRONTAGE (HKEx), RHYTHM PHARMACEUTICALS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), OMEROS CORP (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), JHBP-B (HKEx), BIOXCEL THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ASCENTAGE-B (HKEx), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), INHIBRX INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), VANDA PHARMACE INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RADIUS HEALTH INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MERUS B V (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), HUMANIGEN INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), KINTOR PHARMA-B (HKEx), CURIS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VAXART INC (NASDAQ), COMPUGEN (NASDAQ), VBI VACCINES INC CDA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), AKOUOS INC (NASDAQ), IMMATICS N V (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), ATRECA INC (NASDAQ), AFFIMED N V (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), MAGENTA THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), TERNS PHARMACEUTICALS INC (NASDAQ), LANDOS BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IVERIC BIO INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ALTIMMUNE INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), SINOMAB BIO-B (HKEx), AKEBIA THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ADICET BIO INC (NASDAQ), ESSEX BIO-TECH (HKEx), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), AVROBIO INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), SENSEI BIOTHERAPEUTICS INC (NASDAQ), DECIBEL THERAPEUTICS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), PORTAGE BIOTECH INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), ASCLETIS-B (HKEx), RAPT THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), LEE'S PHARM (HKEx), SESEN BIO INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), XOMA CORP (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), VERASTEM INC (NASDAQ), ONCORUS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), IMMUNOME INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), APTOSE BIOSCIENCES INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), VISTAGEN THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), BIOVIE INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), KAMADA LTD (NASDAQ), CABALETTA BIO INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), INMUNE BIO INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), METACRINE INC (NASDAQ), IMV INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CHIASMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), EQUILLIUM INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), BIOMX INC (NYSE American), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CEL-SCI CORP (NYSE American), HARVARD BIOSCIENCE INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), LONGEVERON INC (NASDAQ), IBIO INC (NYSE American), GLYCOMIMETICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ENZO BIOCHEM INC (NYSE), EVAXION BIOTECH AS SPON ADS EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SYNLOGIC INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ARAVIVE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OTONOMY INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), CAPRICOR THERAPEUTICS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), COHBAR INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ADVAXIS INC (NASDAQ), UNI-BIO GROUP (HKEx), ORGANOVO HLDGS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), MONOPAR THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), AZURRX BIOPHARMA INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), APPLIED DNA SCIENCES INC (NASDAQ), VIRACTA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), VIRIDIAN THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), KIROMIC BIOPHARMA INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ORAGENICS INC (NYSE American), ATYR PHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CYCLO THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), Suntar Eco-City (SGX), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), GEOVAX LABS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), BRIACELL THERAPEUTICS CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), SENESTECH INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ) |